A groundbreaking shift in the country's drug policy has happened, as the regulators permit the use of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were heavily restricted, but a increasing body of research suggests they potentially offer benefits for mental health conditions like depression. This change represent